Lucas Svetlana bought SCTX
July 23, 2026 · Form 4 insider transaction
Lucas Svetlana bought 3,000 shares of Scribe Therapeutics Inc. at $15.00 per share, a transaction worth $45.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,000
Price
$15.00
Total value
$45.0K
InsiderLucas Svetlana
RoleOfficer, Director
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after3,000
OwnershipIndirect
10b5-1 planNo
AmendedNo